Pharma Reviews: IDMA appeals to govt not to discontinue loan licensing and P2P for survival of pharma SMEs

The Indian Drug Manufacturers' Association (IDMA) has urged the government not to discontinue loan licensing and P2P for the survival and ...
Read more: IDMA appeals to govt not to discontinue loan licensing and P2P for survival of pharma SMEs